Anti-photoaging composition, emulsion and preparation method of anti-photoaging composition
By using retinol derivatives in anti-photoaging products, the irritation and stability of retinol in the product is solved, and skin elasticity and collagen synthesis is improved , significantly improve the appearance of skin photoaging.
Patent Information
- Application Number
- CN202411007581.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
AI Technical Summary
The retinol derivatives in existing anti-photoaging products have problems such as high irritation, poor stability and poor transdermality, resulting in skin discomfort and poor effect.
Using an anti-photoaging composition, including retinol, retinol propionate, retinol acetate, retinol palmitate and hydroxyl pinene retinoate, combined with sunflower seed oil and frankincense Resin extract, improves the stability and permeability of retinol through emulsion form.
Significantly improves skin elasticity, gloss and thickness density, increases collagen synthesis, reduces skin appearance changes caused by photoaging, and the lotion has good stability and gentleness.
Smart Images

Figure CN118948679A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of cosmetic preparation, and in particular to an anti-photoaging composition, an emulsion and a preparation method thereof. Background Art
[0002] The skin is the body's first line of defense, playing an important role in resisting external aggression, maintaining the internal environment, and ensuring physiological functions. Skin aging is not only affected by natural aging factors, but is also directly exposed to the external environment and affected by exogenous aging. Exogenous aging is mainly affected by environmental factors, among which ultraviolet rays are the most powerful exogenous factors that cause skin aging. Aging caused by ultraviolet rays is called photoaging. In clinical practice, in addition to skin sagging, obvious dryness, and desquamation, photoaged skin also has photoaging-specific manifestations such as skin thickening, hyperkeratosis, pigmentation, and capillary dilation. Histologically, photoaged skin is characterized by epidermal atrophy and reduced collagen and elastin.
[0003] There are many methods for the clinical treatment of facial skin photoaging, including chemical peels, topical preparations, physical therapy such as laser, radiofrequency, surgical treatment such as botulinum toxin injection, hyaluronic acid filling, etc. All of the above methods can improve the patient's skin quality, but chemical peels, physical indicators, and surgical treatments have defects such as long recovery periods, and there are many complications, such as scar formation, pigmentation, and skin infections. Topical preparations for the skin are a safe and effective means of preventing photoaging and improving the symptoms of photoaging. Retinol is the mainstream of photoaging treatment. Retinol can directly act on epidermal cells, promote epidermal cell DNA synthesis and mitotic index, promote the differentiation of epidermal granular layer cells into keratin, promote the synthesis of extracellular matrix collagen, and inhibit the activity of matrix metalloproteinases caused by photoaging, preventing collagen degradation. Summary of the invention
[0004] Purpose of the invention: The present application provides an anti-photoaging composition, an emulsion and a preparation method thereof. The anti-photoaging composition of the present application can solve the problem of collagen reduction caused by photoaging, improve skin elasticity, enhance skin gloss, and increase skin thickness and density.
[0005] Technical solution: The embodiment of the present application discloses an anti-photoaging composition, comprising at least a first composition, sunflower seed oil and one of frankincense resin extract; the first composition comprises at least two of retinol, retinol propionate, retinol acetate, retinol palmitate and hydroxypinacolone retinoic acid ester.
[0006] In some embodiments, the anti-photoaging composition includes a first composition, sunflower seed oil and frankincense resin extract, and the mass ratio of the first composition, sunflower seed oil and frankincense resin extract is (0.5-2): (0.1-3): (0.5-3).
[0007] In some embodiments, the mass ratio of the first composition, sunflower seed oil and frankincense resin extract is 1:0.5:1.
[0008] In some embodiments, the first composition comprises retinol palmitate and hydroxypinacolone retinoic acid ester in a mass ratio of (0.5-1):(0.5-1).
[0009] In some embodiments, the first composition includes retinyl palmitate and hydroxypinacolone retinoic acid ester in a mass ratio of 1:1.
[0010] The embodiments of the present application also provide an emulsion.
[0011] In some embodiments, the emulsion includes the following components in parts by weight: 1 to 5 parts of an anti-photoaging composition, 1 to 5 parts of an emulsifier, 0.5 to 2 parts of an auxiliary emulsifier, 5 to 15 parts of oil, 0.5 to 2 parts of a thickener, and 0.1 to 1 part of a preservative.
[0012] In some embodiments, based on the total mass of the emulsion, the anti-photoaging composition accounts for 1-5% of the total mass of the emulsion. For example, the anti-photoaging composition accounts for any value among 1%, 2%, 3%, 4%, 5%, or a range consisting of any two values.
[0013] In some embodiments, the emulsifier includes at least one of an olive-derived emulsifier, a glucoside emulsifier, and a monoglyceride emulsifier.
[0014] In some embodiments, the emulsifier comprises an olive oil emulsifier.
[0015] In some embodiments, the emulsifier comprises cetearyl olivate / sorbitan olivate.
[0016] In some embodiments, based on the total mass of the emulsion, the emulsifier accounts for 1-5% of the total mass of the emulsion, such as 1%, 2%, 3%, 4%, 5% or any range consisting of any two values.
[0017] In some embodiments, the co-emulsifier includes at least one of cetearyl alcohol, inulin lauryl carbamate, and sodium stearoyl glutamate.
[0018] In some embodiments, based on the total mass of the emulsion, the co-emulsifier accounts for 0.5-2% of the total mass of the emulsion, such as 0.5%, 1%, 2% or any range consisting of any two values.
[0019] In some embodiments, the thickener includes hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer.
[0020] In some embodiments, based on the total mass of the emulsion, the thickener accounts for 0.5-2% of the total mass of the emulsion, such as 0.5%, 1%, 2% or any range consisting of two values.
[0021] In some embodiments, the oil is at least one of a high-polarity oil, a low-polarity oil, and a medium-polarity oil.
[0022] In some embodiments, the oil comprises caprylic / capric triglyceride.
[0023] In some embodiments, based on the total mass of the emulsion, the oil accounts for 5-15% of the total mass of the emulsion, such as 5%, 10%, 15% or any range consisting of any two values.
[0024] The embodiment of the present application also provides a method for preparing an emulsion, comprising the following steps:
[0025] (1) Accurately weigh the emulsifier, co-emulsifier and oil, and heat them to 80° C. to 85° C. to obtain phase A;
[0026] (2) Weigh water and thickener, heat to 80°C to 85°C to obtain phase B;
[0027] (3) Add phase A to phase B and homogenize at 80-85°C to obtain phase C;
[0028] (4) Accurately weigh the above anti-light aging composition, and mix according to the proportion at room temperature to obtain phase D;
[0029] (5) After cooling phase C to 30°C to 40°C, add phase D and preservatives and stir evenly to obtain an emulsion.
[0030] Beneficial effects: The embodiments of the present application disclose an anti-photoaging composition, an emulsion and a preparation method thereof. The anti-photoaging composition of the present application comprises at least one of a first composition, sunflower seed oil and frankincense resin extract; the first composition comprises at least two of retinol, retinol propionate, retinol acetate, retinol palmitate and hydroxypinacolone retinoic acid ester. The present application further prepares a carrier emulsion in response to the problems of high irritation and poor stability of retinol derivatives. The emulsion of the present application can improve the appearance of photoaging of the skin, improve skin elasticity, skin gloss, increase skin thickness and density, and is mild. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The liquid crystal structure of the emulsion prepared in Example 11 of the present application;
[0032] Figure 2 The wrinkle condition before and after use of the emulsion prepared in Example 11 of the present application observed by VISIA;
[0033] Figure 3 The skin collagen conditions before and after use of the emulsion prepared in Example 11 of the present application were collected using a Dermalab ultrasonic probe. DETAILED DESCRIPTION
[0034] The above contents of the present invention are further described in detail below through examples. For those skilled in the art, it should not be understood that the above subject scope of the present invention is limited to the following examples. The technologies realized based on the above contents of the present invention all belong to the scope of the present invention. The experimental methods used in the following examples are conventional methods unless otherwise specified; the reagents, materials, instruments, etc. used in the following examples can be obtained from commercial sources unless otherwise specified.
[0035] There are three limiting factors in the use of retinoids. The first is irritation: it may cause skin sensations such as desquamation and pain; the second is stability: retinoids are polyol derivatives, and their chemical properties are active and easy to inactivate; the third is transdermal permeability: retinoids are highly lipophilic and not easy to penetrate the stratum corneum. Due to the above reasons, in order to improve the efficacy of retinol products, high levels of retinol are usually added, but retinoid raw materials are mostly irritating and can easily cause symptoms such as skin redness, peeling, and pain. In the prior art, microcapsules, micelles and other technologies are used to solve the problems of retinol instability and irritation, but the microcapsule technology has a low encapsulation capacity, and the addition of the encapsulated retinol derivatives to the product dilutes the retinol content, which does not achieve a good effect. A large amount of surfactants are used in the preparation process of micelles, which may be irritating to the skin; supramolecular gels require the use of gelling agents and cross-linking agents, which are also irritating to the skin. In order to solve at least one of the above problems, an anti-photoaging composition is provided in the embodiment of the present application, comprising at least one of the first composition, sunflower seed oil and frankincense resin extract composition. The first composition at least includes two of retinol, retinol propionate, retinol acetate, retinol palmitate and hydroxypinacolone retinoic acid ester. Retinol and its derivatives can inhibit the activity of matrix metalloproteinases, promote the synthesis of collagen, and reduce the changes in skin appearance caused by photoaging. Sunflower seed oil is rich in vitamin E and unsaturated fatty acids, which can synergistically resist photoaging, and also has antioxidant effect and contributes to the stability of the system. Frankincense resin extract is rich in boswellic acid and paeonol substances, and has antioxidant effect. The present application improves the anti-photoaging performance by compounding sunflower seed oil and frankincense resin extract with retinol derivatives.
[0036] In some embodiments, the first composition comprises retinol palmitate and hydroxypinacolone retinoic acid ester in a mass ratio of (0.5-1):(0.5-1). The present application improves the anti-photoaging performance by compounding retinol derivatives.
[0037] In some embodiments, the present application provides an emulsion, and in other specific embodiments, the emulsion is a lamellar liquid crystal emulsion. The present application forms a lamellar liquid crystal emulsion by screening emulsifiers, co-emulsifiers, and oils in the emulsion. The emulsion has a distinct liquid crystal structure, strong stability, and is conducive to the penetration of active substances.
[0038] In some embodiments, the emulsion includes the following components by weight: 1 to 5 parts of an anti-photoaging composition, 1 to 5 parts of an emulsifier, 0.5 to 2 parts of an emulsifier, 5 to 15 parts of oil, 0.5 to 2 parts of a thickener, and 0.1 to 1 parts of a preservative. The present application further adds an anti-photoaging composition and an antioxidant to the emulsion, which increases the retention rate of retinol derivatives, has low irritation, and can significantly improve the appearance of photoaging of the skin, such as skin elasticity, skin color, skin moisture, and skin wrinkles.
[0039] In some embodiments, the emulsion includes the following components in parts by weight: 2.5 parts of an anti-photoaging composition, 3 parts of an emulsifier, 2 parts of an auxiliary emulsifier, 10 parts of oil, 0.6 parts of a thickener, and 0.1 to 1 parts of a preservative.
[0040] In some embodiments, the emulsifier includes at least one of an olive-derived emulsifier, a glucoside emulsifier, and a monoglyceride emulsifier.
[0041] In some embodiments, the olive-derived emulsifier comprises an olive oil emulsifier, and in some specific embodiments, the emulsifier comprises cetearyl olivate / sorbitan olivate (Olivem 1000).
[0042] In some embodiments, the thickener includes hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer.
[0043] In some embodiments, the co-emulsifier includes at least one of cetearyl alcohol, sodium stearoyl glutamate, and inulin lauryl carbamate.
[0044] In some embodiments, the oil is at least one of a high polarity oil, a low polarity oil, and a medium polarity oil.
[0045] In some embodiments, the oil is a medium polar oil. In other specific embodiments, the oil is caprylic / capric triglyceride.
[0046] In the embodiments of the present application, retinol comes from Shanghai Ruixi Trading Co., Ltd.; encapsulated retinol comes from Givaudan Daily Flavors and Fragrances (Shanghai) Co., Ltd.; hydroxypinacolone retinoic acid ester (HPR) comes from Shanghai Keqin Technology Co., Ltd.; retinol propionate comes from BASF (China) Co., Ltd., and retinol palmitate comes from DSM of the Netherlands; encapsulated hydroxypinacolone retinoic acid ester (SHINE+Supra HPR liposome) comes from Guangdong Xuanjia Medical Health Technology Co., Ltd.; sunflower seed oil comes from Lebocon, USA; frankincense resin extract comes from Shanghai Ruixi Trading Co., Ltd.; olive-derived emulsifier (Olivem 1000) is cetearyl olivate / sorbitan olivate from Shanghai Ronghai Biotechnology Co., Ltd.; glucoside emulsifier (MONTANOV 68MB) is cetearyl glucoside / cetearyl alcohol from Seppic, France; monoglyceride emulsifier (SIMUSOL 165) is glyceryl stearate / PEG-100 stearate from Seppic, France; cetearyl alcohol from BASF (China) Co., Ltd.; inulin lauryl carbamate from Cintin, France; sodium stearoyl glutamate from BASF (China) Co., Ltd.; olive oil from Shanghai Ruixi Co., Ltd.; caprylic / capric triglyceride from BASF (China) Co., Ltd.; squalane from Shanghai Ruixi Co., Ltd.; glycerin and butylene glycol from Shanghai Xinzhide Industrial Development Co., Ltd.; hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer from Seppic, France; phenoxyethanol / ethylhexylglycerin (PE9010) from Shanghai Biohobo Biotechnology Co., Ltd.
[0047] Example 1: Anti-photoaging composition test
[0048] 1.1 Test on the promotion of type I collagen gene expression by retinol derivatives in zebrafish
[0049] Photoaging can cause collagen loss, so this experiment uses collagen promotion indicators to evaluate the effect of retinol derivatives. Collagen is the most abundant protein in the human extracellular matrix, and type I collagen is the most abundant protein in the skin. The distribution of type I collagen in zebrafish is the same as that in humans. The expression of zebrafish type I collagen genes (col1a1a, col1a1b and col1a2) was tested, and the relative expression of zebrafish type I collagen genes in the control group and sample group was compared. The promotion rate of type I collagen gene expression was calculated to evaluate the anti-wrinkle and firming effect of the raw materials or products.
[0050] Test method:
[0051] 1.1.1 Test organisms: Spawning test of wild-type AB strain zebrafish (Danio rerio, China National Zebrafish Resource Center). Parent fish are selected with good reproductive ability, and the best age is 6 to 12 months. Cross-crossing is used for procreation to maintain genetic diversity. A new batch of parent fish needs to be replaced after 5 generations of pure strain parent fish. Parent fish should not have obvious visible signs of infection and disease, and have not undergone drug treatment within 2 months. Before the breeding and spawning test, the parent fish should be domesticated for more than 14 days after being introduced into the laboratory.
[0052] 1.1.2 Breeding requirements: The water temperature should be controlled at 26℃~28.5℃, and the indoor temperature is recommended to be controlled at 20℃~25℃. The breeding density should be controlled at 1~2 fish per liter of water, and the light should be fixed at 12h~16h per day, and a good filtration system should be maintained. Feed at least 2 times a day, including at least 1 time of brine shrimp (Artemia salina) larvae, with a feeding interval of more than 3 hours to avoid overfeeding that affects water quality and cleanliness.
[0053] 1.1.3 Requirements for spawning: Use a spawning tank to collect fish eggs. Place male and female fish in a ratio of 2:1 into the spawning tank 1 to 2 hours before turning off the lights on the day before spawning. Since zebrafish occasionally do not spawn, it is recommended to prepare multiple spawning tanks for backup. To avoid genetic bias, mix the fish eggs collected from at least 3 spawning tanks and then select them for backup. If using a culture fish tank to collect fish eggs, place the egg collection box into the culture fish tank where the fish eggs are to be collected before turning off the lights on the day before spawning or before turning on the lights on the day of spawning. To prevent the eggs from being eaten by adult fish, cover the egg collection box with an inert net. Mating, spawning and fertilization are completed within about 30 minutes after turning on the lights, and the egg collection box can be removed from the fish tank at that time. After the fish eggs are removed from the egg collection box, it is recommended to clean the fish embryos with fish embryo culture medium. Select healthy zebrafish embryos and culture them at a density of no more than 1 fish embryo in 200μL fish embryo culture medium at 28℃±1℃ until 6 days after fertilization.
[0054] 1.1.4 Preparation of test substances: Select dimethyl sulfoxide as solvent to assist dissolution, and prepare sample solutions with a mass percentage concentration of 0.5% for encapsulated retinol, retinol, retinol propionate, and encapsulated hydroxypinacolone retinoic acid ester. Prepare sample solutions with a mass percentage concentration of 0.2%, 0.5%, and 1.0% for retinol palmitate and hydroxypinacolone retinoic acid ester, respectively.
[0055] 1.1.5 Test steps: Select healthy zebrafish 6 days after fertilization. Randomly select 36 zebrafish and evenly distribute them into 24-well plates, set up 3 wells, each well contains 12 zebrafish and 2.5mL test solution. Place in a 28℃±1℃ incubator for 24h±1h. Collect 12 zebrafish in each well into a 1.5mL tube, remove the solution, add 0.5mL RNAlater solution, and store frozen. Remove RNAlater solution and rinse with PBS solution 3 times. Place in an ice bath, remove PBS solution, and add 500μL TRIzol reagent. Homogenize the embryos with a pellet pestle and place in an ice bath for 10min. Add 100μL chloroform, vortex for 1min, and place in an ice bath for 5min. Centrifuge the sample for 20min, transfer the upper solution to a 1.5mL centrifuge tube, add 250μL isopropanol, vortex for 1min, place in an ice bath for 10min, and centrifuge the sample for 20min. Remove all supernatant, add 500 μL ethanol, vortex for 1 min, centrifuge the sample for 5 min, and place in an ice bath for 10 min. Repeat this step 3 times. Remove ethanol, centrifuge the sample for 5 min, and open the lid in a fume hood to air-dry the sample for 10 min. Add 10 μL DNase / RNase-free ultrapure distilled water and heat at 55°C for 15 min. cDNA synthesis: Dilute the RNA sample to 1000 ng / 7 μL with DNase / RNase-free ultrapure distilled water. Use the PrimeScript RT kit containing gDNA Eraser (Takara; Cat no.RR047A) to synthesize RNA into cDNA and store frozen. For real-time RT-PCR, prepare primer mixtures for each primer and seal 96-well plates for PCR with solid optical film, centrifuge the well plates for 5 min, and perform real-time PCR amplification.
[0056] 1.1.6 Data and result calculation: Real-time PCR data were collected. Ct was used as the amplification result, the amplification amount of β-actin gene was used as the housekeeping gene, and the relative expression of each gene (col1a1a, col1a1b and col1a2) was calculated as the test result.
[0057]
[0058] Among them, the relative expression of genes = 2 -ΔΔCt ;
[0059] ΔΔCt=ΔCt 空白对照组 Mean-ΔCt 受试物 ;
[0060]
[0061] △Ct: the difference between the cycle number of the target gene and the cycle number of the housekeeping gene;
[0062] The number of cycles it takes for the fluorescence signal of the target gene to reach the set threshold;
[0063] The number of cycles it takes for the fluorescent signal of the housekeeping gene to reach the set value;
[0064] △△Ct: the difference between the average △Ct of the control group and the △Ct of the test substance group;
[0065] ΔCt 空白对照组 : The average value of the difference between the cycle number of the target gene in the blank control group and the cycle number of the housekeeping gene;
[0066] △Ct 受试物 : The difference between the cycle number of the target gene and the cycle number of the housekeeping gene in the test substance group;
[0067] The collagen gene expression promotion rate is a positive number, and the test result can be used as supporting evidence that the test substance has the ability to promote collagen regeneration, and the higher the value, the higher the ability to promote type I collagen production.
[0068] Table 1 Test results of promoting the expression of type I collagen gene in test examples 1 to 11
[0069]
[0070]
[0071] From the results in Table 1, it can be seen that the 0.2% content of the three concentration gradients of hydroxypinacolone retinoic acid ester and retinol palmitate promotes a lower expression rate of type I collagen, indicating that the concentration of 0.2% has not reached its optimal concentration for efficacy, and the 1% content has a lower expression rate of type I collagen, which may be because the 1% content has a certain toxicity to the zebrafish model, so the expression rate of type I collagen is low. Test Examples 3 and 9 promote a higher expression rate of type I collagen in zebrafish. When the two are combined, the expression rate of type I collagen in zebrafish is higher. The embodiment of the present application selects a hydroxypinacolone retinoic acid ester with a mass percentage concentration of 0.5% and a retinol palmitate with a mass percentage concentration of 0.5% as the first composition in the anti-photoaging composition.
[0072] Example 2: Emulsion system selection
[0073] According to the specific components in Table 2, the emulsion was prepared by weight.
[0074] (1) Accurately weigh the emulsifier, co-emulsifier, and oil, and heat them to 80-85° C. to obtain phase A;
[0075] (2) Weigh water (based on 100 parts by weight of the total amount of the emulsion, the water is supplemented to 100 parts by weight), a thickener or a water-soluble co-emulsifier, and heat to 80-85° C. to obtain phase B;
[0076] (3) Add phase A to phase B and homogenize at 80-85°C for 10 min to obtain phase C;
[0077] (4) After cooling phase C to 40°C, add phase D and mix well.
[0078] Table 2 Emulsion components of Examples 1 to 10 (by mass)
[0079]
[0080]
[0081] The emulsion prepared in Example 2 was subjected to a stability test. The stability test indicators included appearance indicators such as product color and properties, and also included the stability of the active substance content in the sample.
[0082] Test method:
[0083] Centrifugal stability: Place the product in a centrifuge (the centrifugal test condition is 2000r / min, 30min), take it out and observe the product status. If the product is stratified, it is judged to be unstable. If the product status is normal, it is judged to be centrifugally stable.
[0084] 40℃ and freeze-thaw stability: The experiment uses Turbiscan Lab stability analyzer (Turbiscan Lab, Formulaction, France) to evaluate its stability and uniformity. The instrument can judge the stability of the product in a relatively short time. Specifically, using an 880nm near-infrared light source, the stability of the sample is reflected by detecting the changes in the intensity of the projected light and backscattered light of the sample. The Turbiscan Lab stability analyzer can judge the aggregation and flocculation conditions of the dispersed particles in the system in a relatively short time, and can reflect the changes in the internal structure of the emulsion to a certain extent. The experimental conditions are heat resistance (40℃, 24h) and freeze-thaw (-20℃, 24h). Among them, when the absolute value of ΔBS is <5%, it indicates absolute stability; when the absolute value of ΔBS is 5%<ΔBS<8%, it indicates moderate stability; when the absolute value of ΔBS is >8%, it indicates instability.
[0085] Liquid crystal structure: Take an emulsion sample and observe the liquid crystal structure of the emulsion under a polarized light microscope. Take a small amount of the sample and place it on a glass slide and flatten it with a cover glass. Adjust the brightness knob to obtain the appropriate brightness. Insert the polarized light plug-in and observe whether the liquid crystal structure appears and the number of liquid crystal structures under the condition of 400 times magnification. The liquid crystal structure is in the shape of a Maltese cross and appears blue fluorescent under a polarized light microscope. Take a picture of the sample for analysis. If there are more blue fluorescent Maltese crosses in the picture and the brightness is high, it is judged that there are more liquid crystal structures. If there are fewer blue fluorescent Maltese crosses in the picture and the brightness is low, it is judged that there are fewer liquid crystal structures.
[0086] Table 3 Test results of the emulsions of Examples 1 to 10
[0087]
[0088] Note: “×” indicates that the emulsion has stratification, “√” indicates that there is no visible stratification after centrifugation, and “ / ” indicates that no liquid crystal structure is observed.
[0089] According to the results in Table 3, the present application selects the components of Example 1 as the emulsion components. The components of the emulsion form more regular liquid crystal structures, which are beneficial to the penetration of active substances.
[0090] Example 3: Screening of anti-photoaging compositions
[0091] According to the specific components in Table 4, the emulsion was prepared by weight.
[0092] (1) Accurately weigh the emulsifier, co-emulsifier, and oil, and heat them to 80-85° C. to obtain phase A;
[0093] (2) Weigh water (based on 100 parts by weight of the total amount of the emulsion, the water is supplemented to 100 parts by weight), a thickener or a water-soluble co-emulsifier, and heat to 80-85° C. to obtain phase B;
[0094] (3) Add phase A to phase B and homogenize at 80-85°C for 10 min to obtain phase C;
[0095] (4) accurately weighing the anti-light aging composition and mixing it according to the proportion at room temperature to obtain phase D;
[0096] (5) After cooling phase C to 30°C to 40°C, add phase D and preservatives and stir evenly to obtain an emulsion.
[0097] Table 4 Emulsion components of Example 11 to Example 17 (by mass)
[0098]
[0099] Test method for retention rate of hydroxypinacolone retinoic acid ester (HRP): The retention rate of hydroxypinacolone retinoic acid ester before and after in the sample is determined by high performance liquid chromatography, retention rate = N1 / N2*100, N1 represents the content of hydroxypinacolone retinoic acid ester in the 30-day emulsion, and N2 represents the content of hydroxypinacolone retinoic acid ester in the initial emulsion. Agilent 1260 high performance liquid chromatograph, diode array detector, Thermo Fisher Hypersil GOLD chromatographic column, flow rate 1ml / min, column temperature 35°C, mobile phase: A methanol + B 0.01mol / L potassium dihydrogen phosphate + C isopropanol = 5% + 5% + 90%, detection wavelength is 380nm.
[0100] Test method for the retention rate of retinol palmitate: The retention rate of retinol palmitate before and after in the sample was determined by high performance liquid chromatography, and the retention rate = M1 / M2*100, M1 represents the content of retinol palmitate in the 30-day emulsion, and M2 represents the content of retinol palmitate in the initial emulsion. Agilent 1260 high performance liquid chromatograph, diode array detector, Thermo Fisher Hypersil GOLD column, flow rate 1ml / min, column temperature 35°C, mobile phase: A methanol + B 0.01mol / L potassium dihydrogen phosphate + C isopropanol = 5% + 5% + 90%, detection wavelength 325nm.
[0101] How to judge stimulation:
[0102] The test organisms used were wild-type AB strain zebrafish (Danio rerio, China National Zebrafish Resource Center) for spawning tests. Broodstock should have good reproductive capacity - the best age is 6 to 12 months. Cross-crossing should be used as much as possible to maintain genetic diversity. A new batch of broodstock should be replaced after 5 generations of pure strain broodstock. Broodstock should not have obvious visible signs of infection and disease, and should not have undergone drug treatment within 2 months. Broodstock should be domesticated for more than 14 days after being introduced into the laboratory before spawning tests.
[0103] Breeding requirements: The water temperature should be controlled at 26-28.5℃, and the indoor temperature is recommended to be controlled at 20-25℃. 7.2.2 The breeding density should be controlled at 1-2 fish per liter of water, and the light should be fixed at 12-16 hours per day, and a good filtration system should be maintained. Feed at least twice a day, including at least 1 brine shrimp (Artemia salina) larvae, with a feeding interval of more than 3 hours to avoid overfeeding that affects water quality and cleanliness. If you use a spawning tank to collect fish eggs, it is advisable to put male and female fish in the spawning tank at a ratio of 2:1 1-2 hours before turning off the lights on the day before spawning. Since zebrafish occasionally do not spawn, it is recommended to prepare multiple spawning tanks at the same time. To avoid genetic deviation, mix the fish eggs collected from at least 3 spawning tanks and then select them for use. If you use a breeding fish tank to collect fish eggs, put the egg collection box in the breeding fish tank where the fish eggs are to be collected before turning off the lights on the day before spawning or before turning on the lights on the day of spawning. To prevent the eggs from being eaten by adult fish, the egg box is covered with an inert net. Mating, spawning and fertilization are completed within about 30 minutes after turning on the lights, and the egg box can be removed from the fish tank at that time. After the eggs are removed from the egg box, it is recommended to clean the fish embryos with fish embryo culture medium. Select healthy zebrafish embryos and culture them at a density of no more than 1 fish embryo in 200μL fish embryo culture medium at 28±1℃ until 3 days after fertilization.
[0104] Sample preparation: Add Examples 11 to 17 into fish embryo culture medium to prepare a solution with a sample concentration of 5 g / L, shake for 30 seconds, and centrifuge at 6500×g for 10 minutes. Take the supernatant for testing.
[0105] Injury model: Zebrafish embryos were anesthetized with tricaine solution, and the caudal fins of zebrafish embryos were removed with a laboratory scalpel under a microscope.
[0106] Fish embryo fixation and staining: After each test group of fish embryos were fixed in paraformaldehyde for at least 1 hour, the fish embryos were treated with PBST 3 times, each time for 5 minutes, and then treated with 50% ethanol for 3 minutes. After the fish embryos were stained with Sudan black staining solution at room temperature for 1 hour, they were immersed in 70% ethanol 4 times, each time for 5 minutes, and then treated with PBST twice, each time for 5 minutes. The fish embryos were treated with bleach solution for 10 minutes. If they were treated in a test tube, the lid should be kept open. Then they were treated with 70% ethanol solution for 5 minutes, PBST for 1 minute, clear solution 1 for 15 minutes, clear solution 2 for 10 minutes, and PBST for 3 minutes.
[0107] Microscopic analysis of the sample: The fish embryo was placed on its side. Then the tail of the fish embryo was photographed under a stereo microscope.
[0108] Data and results calculation: The number of neutrophils in the caudal fin resection area of each fish embryo was counted.
[0109] Neutrophil aggregation promotion rate = average number of neutrophil numbers in fish embryos of the test substance treatment group - average number of neutrophil numbers in fish embryos of the model control group / average number of neutrophil numbers in fish embryos of the model control group × 100%; a positive number for neutrophil aggregation promotion rate indicates that the test substance has a stimulating effect; a negative number for neutrophil aggregation promotion rate indicates that the test substance has no stimulating effect. The larger the absolute value of the neutrophil aggregation promotion rate, the milder it is.
[0110] The test results are shown in Table 5.
[0111] Table 5 Test results of Examples 11 to 17
[0112]
[0113] Through the test, it was found that compared with the result of Example 11, the active substance retention rate of Examples 16 and 17 was lower, indicating that the use of sunflower seed oil and frankincense resin extract together can greatly improve the active preservation rate of the active substance. Compared with Example 11, the active substance retention rate in Examples 12 and 14 was reduced, indicating that reducing the amount of sunflower seed oil and frankincense resin used would also reduce the active substance retention rate. Compared with Example 11, the active substance retention rate of Example 13 was reduced, indicating that when the content of sunflower seed oil was high, the active substance retention rate was reduced, which may be because sunflower seed oil is a vegetable oil, and when the content is high, it leads to the instability of the emulsion and thus affects the stability of the active substance. When sunflower seed oil and frankincense resin extract are used in proportion, the active substance retention rate can be improved. Compared with Example 11, Example 15 is more irritating, and the reason for the analysis is that the frankincense resin extract will have a certain irritation when the content becomes larger.
[0114] From the results in Table 5, it can be seen that the content and combination of sunflower seed oil and frankincense resin extract will affect the mildness of the lotion. And the irritation of retinol derivatives can be reduced by compounding sunflower seed oil and frankincense resin extract.
[0115] Example 4: Performance test of the product prepared in Example 11
[0116] Human efficacy test: Screen healthy adults aged 20 to 45 years (both men and women), without severe systemic diseases, immunodeficiency or autoimmune diseases, active allergic diseases, no history of severe allergies to cosmetics, no use of hormone drugs and immunosuppressants in the past month, no scars, pigments, atrophy, port wine stains or other blemishes on the skin test site that affect the determination of the test results, no participation in other clinical tests, use the test substance as required and have complete information, and sign the informed consent form before the test. 20 target subjects were selected and the emulsion prepared in Example 11 was used. The subjects took an appropriate amount of the product and evenly applied it on the face before going out every morning, and the volunteers were tested on the skin at week 0 and week 4.
[0117] Skin elasticity test: Use Dermalab high-frequency skin elasticity detection probe (Denmark Cortex Company, Dermalab Series SkinLab) to test the skin rebound time R value. The R value represents an indicator to measure whether the tested sample has the ability to improve skin elasticity. The larger the R value, the better the effect of improving skin elasticity. Conversely, the smaller the R value, the worse the skin elasticity effect. The test records the R values at week 0 and week 4, recorded as R0 and R4 respectively, and calculates the elasticity improvement rate. The higher the improvement rate, the better the skin elasticity improvement effect. Skin elasticity improvement rate (%) = R0-R4 / R0.
[0118] Skin chromaticity: Use the Dermalab chromaticity probe to test skin chromaticity. CIEL*a*b* is the skin color encoded in the CIELab color space. This measurement method is used to measure the color of the skin. Each measurement gives 3 values (L*, a*, b*), where L* is the brightness of the skin. The higher the L* value, the brighter the skin. (a*, b*) are indicators of skin color. The higher the a* value, the redder the skin. The higher the b* value, the yellower the skin. In this experiment, the L* value was selected as the chromaticity index. The L values at week 0 and week 4 were recorded, denoted as L0 and L4, respectively. The skin chromaticity improvement rate was calculated. The higher the ratio, the better the skin chromaticity improvement effect. Skin chromaticity improvement rate (%) = L4-L0 / L0×100%.
[0119] Use VISIA to take facial photos and observe facial wrinkles.
[0120] The Dermalab ultrasound probe is used to obtain ultrasound images and analyze skin thickness and density data. In the collagen measurement image, the color indicates the intensity (strength) of the reflected ultrasound signal. Dark colors indicate low intensity, while white (yellow) indicates high intensity. The epidermis is highly reflective (white / yellowish) and the dermis is a mixture of multiple colors. Subcutaneous fat and muscle fibers will return low-intensity signals (dark green and black). Generally, uniform areas and tissues (such as fluids, blood, fat, etc.) have low reflectivity and appear darker; non-uniform structures (such as healthy skin with intact collagen, elastin, and connective tissue) cause reflections of varying intensity due to changes in acoustic properties (i.e., density changes in the tissue). In other words, the higher the skin density, the higher the content of intact collagen, elastin, and connective tissue.
[0121] Table 6 Elasticity test results of the emulsion prepared in this application
[0122] Group Week 0 R value R value at week 4 Improvement rate Embodiment 11 182.14285 175.71428 3.53%
[0123] Table 7 Chromaticity performance test results of the emulsion prepared in this application
[0124] Group L value at week 0 L value at week 4 Improvement rate Embodiment 11 63.26 63.69 0.68%
[0125] Table 8 Skin thickness performance test results of the lotion prepared in this application
[0126] Group Skin thickness at week 0 (μm) Skin thickness at 4th week (μm) Improvement rate Embodiment 11 1065.57 1102.79 3.49%
[0127] Table 9 Skin density performance test results of the lotion prepared in this application
[0128] Group Skin strength at week 0 (μm) Skin strength at week 4 (μm) Improvement rate Embodiment 11 55.71 60.23 8.12%
[0129] It can be seen from the test results in Tables 6 to 9 that the emulsion prepared in Example 11 has the effect of improving skin elasticity, chromaticity, skin thickness and density.
[0130] VISIA image test: VISIA was used to collect the wrinkle conditions of the subjects in Example 11. A typical example is Figure 2 The Dermalab ultrasonic probe was used to collect the skin collagen of the subjects in Example 11. A typical case is as follows: Figure 3 shown. Figure 2 The normal texture in the middle indicates the skin texture of the subject under VISIA normal light. In the 4th week, the fine lines at the corners of the subject's eyes became lighter. The color map texture is the color table view of the normal texture, which makes the observation of wrinkles more intuitive. In the 4th week, the deep wrinkles became lighter. Figure 3The middle color indicates the intensity of the reflected ultrasound signal. The more white (yellow) matter there is, the stronger the signal is and the higher the collagen content is. It can be found that the amount of white (yellow) matter increases in the 4th week, indicating that the collagen content in the skin increases in the 4th week.
Claims
1. An anti-photoaging composition, characterized in that: The invention comprises at least one of a first composition, sunflower seed oil and frankincense resin extract; the first composition comprises at least two of retinol, retinol propionate, retinol acetate, retinol palmitate and hydroxypinacolone retinoic acid ester.
2. The anti-photoaging composition according to claim 1, characterized in that: The anti-photoaging composition comprises a first composition, sunflower seed oil and frankincense resin extract, wherein the mass ratio of the first composition, sunflower seed oil and frankincense resin extract is (0.5-2): (0.1-3): (0.5-3).
3. The anti-photoaging composition according to claim 1, characterized in that: The first composition comprises retinol palmitate and hydroxypinacolone retinoic acid ester in a mass ratio of (0.5-1):(0.5-1).
4. An emulsion, characterized in that The invention comprises the anti-photoaging composition as claimed in any one of claims 1 to 3.
5. The emulsion according to claim 4, characterized in that The emulsion comprises the following components in parts by weight: 1 to 5 parts of an anti-light aging composition, 1 to 5 parts of an emulsifier, 0.5 to 2 parts of an auxiliary emulsifier, 5 to 15 parts of oil, 0.5 to 2 parts of a thickener and 0.1 to 1 part of a preservative.
6. The emulsion according to claim 5, characterized in that The emulsifier includes at least one of an olive-derived emulsifier, a glucoside emulsifier, and a monoglyceride emulsifier.
7. The emulsion according to claim 5, characterized in that The auxiliary emulsifier includes at least one of cetearyl alcohol, inulin lauryl carbamate and sodium stearoyl glutamate.
8. The emulsion according to claim 5, characterized in that The thickener includes hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer.
9. The emulsion according to claim 5, characterized in that The oil includes at least one of polar oil, medium-polar oil and non-polar oil.
10. A method for preparing an emulsion, characterized in that: The following steps are involved: (1) Accurately weigh the emulsifier, co-emulsifier and oil, and heat them to 80° C. to 85° C. to obtain phase A; (2) Weigh water and thickener, heat to 80°C to 85°C to obtain phase B; (3) Add phase A to phase B and homogenize at 80°C to 85°C to obtain phase C; (4) accurately weighing the anti-light aging composition as claimed in claim 1, and mixing according to the proportion at room temperature to obtain phase D; (5) After cooling phase C to 30°C to 40°C, add phase D and preservatives and stir evenly to obtain an emulsion.
